Analysis platform and consumables for a screening test of high risk humant papillomavirus (HPV) for the University Hospital of North Norway

Description

1 analysis platform for a screening test of high risk humant papillomvirus (HPV). The accompanying reagents and instrument specific consumables must be included. The HPV tests must fulfil the requirements for primary screening and secondary screening in accordance with the Cancer Register's requirements. Further information can be found on the Cancer Register's homepage. https://www.kreftregisteret.no/screening/livmorhalsprogrammet/ The estimated number of analyses is 20,000 a year. The stated consumption/scope is an estimate for information to the tenderer, and is not binding for future contract volume. Lot 1: See the tender documentation for a further description.